Achaogen inc stock

Apr 15, 2019 · Nanocap biotech Achaogen Inc (NASDAQ: AKAO) has been pushed to the brink, Split Verdict Chokes Stock. The writing on the wall was clear after Achaogen's lead product candidate Zemdri, or Achaogen, Inc. Announces Results of Auction for ... Jun 06, 2019 · SOUTH SAN FRANCISCO, Calif., June 06, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative

Achaogen Inc. Stock Price (AKAOQ) | Barron's Jan 31, 2020 · View today's stock price, news and analysis for Achaogen Inc. (AKAOQ). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Achaogen, Inc. 10-Q May. 7, 2018 9:38 AM | Seeking Alpha Achaogen, Inc. (together with its consolidated subsidiary, the “Company”) is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization AKAO Stock Quote - Achaogen, Inc. Stock Price Today Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections.

Achaogen Inc - Ordinary Shares (AKAOQ) Stock Quotes | Nasdaq

Jan 31, 2020 · View today's stock price, news and analysis for Achaogen Inc. (AKAOQ). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Achaogen, Inc. 10-Q May. 7, 2018 9:38 AM | Seeking Alpha Achaogen, Inc. (together with its consolidated subsidiary, the “Company”) is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization AKAO Stock Quote - Achaogen, Inc. Stock Price Today Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. AKAO Institutional Ownership - Achaogen, Inc. Stock Achaogen, Inc. (NASDAQ:AKAO) has 14 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a …

Mar 24, 2020 · Find out if AKAOQ is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on AKAOQ.

2 Sep 2019 Since its inception, Achaogen has financed its operations with the proceeds from its initial public offering (“IPO”) of its common stock, proceeds  15 Apr 2019 Achaogen wants to sell itself through an auction as a part of a Chapter 11 bankruptcy reorganization, which the antibacterial-product maker  26 Jun 2018 Achaogen Inc (NASDAQ: AKAO) is havinga rough start to the trading session this morning, and for good reason. The company released news 

The antibiotic market is broken, one expert said. "Policymakers must take this as a clarion call to act now."

AKAO Stock Quote - Achaogen Inc - Bloomberg Markets Stock analysis for Achaogen Inc (AKAO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Achaogen - AKAO - Stock Price & News | The Motley Fool Apr 03, 2020 · Real time Achaogen (AKAO) stock price quote, stock graph, The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. ACHAOGEN INC. Exchange AKAO Achaogen Inc. — Stock Price and Discussion | Stocktwits Jun 28, 2019 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

5 Jul 2018 Crowdsourced stock and analyst ratings and analysis for Achaogen, Inc. ($AKAO ) from the leading crowdsourced stock rating platform.

AKAO: Dividend Date & History for Achaogen Inc Achaogen Inc (AKAO) Stock Dividend Data. AKAO Stock Dividend Data. Dividend Yield Dividend Yield. Dividend yield is the relation between a stock’s annual dividend payout and its current stock price. Click here to learn more. 0.00% healthcare Average 0.01% ANNUALIZED PAYOUT Annualized Payout. AKAOQ - Achaogen Inc Stock quote - CNNMoney.com Find real-time AKAOQ - Achaogen Inc stock quotes, company profile, news and forecasts from CNN Business. Achaogen, Inc. On April 15, 2019, Achaogen, Inc. filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”). The case is administered under Case No. 19-10844 before the Honorable Brendan Linehan Shannon, in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”).

Delivery of the shares of common stock will be made on or about , 2014. in this prospectus to “Achaogen,” “we,” “us” and “our” refer to Achaogen, Inc., and our  Achaogen, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes  Achaogen, a biopharmaceutical company, discovers and develops broad- spectrum Type Post-IPO Equity Number of Employees 101-250 Legal Name Achaogen Inc. IPO Status Public Stock Symbol NASDAQ:AKAO Company Type For Profit.